BackPharma Equity Group A/S Overview
Pharma Equity Group A/S

Pharma Equity Group A/S Return on Equity

Pharma Equity Group A/S (PEG.CO) has a ROE of -71.99%, below the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

-71.99%

Return on Equity

-71.99%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Pharma Equity Group A/S (PEG.CO) FAQ

The latest ROE for PEG.CO is -71.99%. That is below the Healthcare sector average of 13.1%. Investors often review this figure alongside Pharma Equity Group A/S's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, PEG.CO currently prints -71.99% for ROE, while the sector average sits near 13.1%. That is roughly 649.4% below the sector mean. Large gaps often invite a closer look at Pharma Equity Group A/S's growth, margins, and balance sheet.

Return on Equity shows how effectively Pharma Equity Group A/S converts resources into returns. At -71.99%, PEG.CO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PEG.CO's ROE (-71.99%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pharma Equity Group A/S's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.